← Leaderboards
Mark A. Lemmon
Yale University
$27,011,161
Attributed
$33,449,624
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,449,624 · 16
By mechanism
R01$24,619,901 · 10
R35$7,165,580 · 1
P50$1,419,951 · 2
R21$237,750 · 1
P41$6,442 · 2
Top collaborators
- Kathryn M Ferguson10 shared
- William S. Hlavacek5 shared
- Boris N Kholodenko5 shared
- Diane Lidke5 shared
- Ravi Radhakrishnan5 shared
Most similar at Yale University
Same institution · by research overlap
- Boris N Kholodenko$3,772,867
- Ravi Radhakrishnan$6,158,626
- Krishna Chaitanya Mudumbi$442,756
- Wei Zhang$99,802
- John J Wysolmerski$21,872,124
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionMalignant NeoplasmsLigandsStructureReceptorInsightBiochemicalDimerReceptor Protein-Tyrosine KinasesComplexReceptor SignalingFamilyBasePropertyFamily MemberEpidermal Growth Factor ReceptorCellsResponsePlayDimerizationMutationExtracellularKinase InhibitorReceptor Activation
Grant awards (84)
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$770,500
R35 · FY2025 · GM · contact PI
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$770,500
R35 · FY2024 · GM · contact PI
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling$643,676
R01 · FY2024 · CA · contact PI
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses$502,337
R01 · FY2024 · CA · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$487,870
R01 · FY2024 · CA · contact PI
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck$351,519
P50 · FY2024 · DE · contact PI
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$770,500
R35 · FY2023 · GM · contact PI
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling$669,574
R01 · FY2023 · CA · contact PI
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses$518,201
R01 · FY2023 · CA · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$511,569
R01 · FY2023 · CA · contact PI
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck$357,079
P50 · FY2023 · DE · contact PI
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$770,500
R35 · FY2022 · GM · contact PI
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling$674,422
R01 · FY2022 · CA · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$520,743
R01 · FY2022 · CA · contact PI
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses$518,201
R01 · FY2022 · CA · contact PI
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck$354,275
P50 · FY2022 · DE · contact PI
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$803,411
R35 · FY2021 · GM · contact PI
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling$693,342
R01 · FY2021 · CA · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$539,744
R01 · FY2021 · CA · contact PI
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses$528,777
R01 · FY2021 · CA · contact PI
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck$357,078
P50 · FY2021 · DE · contact PI
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$803,411
R35 · FY2020 · GM · contact PI
Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling$737,149
R01 · FY2020 · CA · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$548,181
R01 · FY2020 · CA · contact PI
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses$528,890
R01 · FY2020 · CA · contact PI
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$793,758
R35 · FY2019 · GM · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$504,807
R01 · FY2019 · CA · contact PI
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$804,000
R35 · FY2018 · GM · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$520,420
R01 · FY2018 · CA · contact PI
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$75,000
R35 · FY2018 · GM · contact PI
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases$804,000
R35 · FY2017 · GM · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$535,711
R01 · FY2017 · CA · contact PI
Understanding Wnt signaling through Ror and Ryk family receptor tyrosine kinases$532,050
R01 · FY2016 · GM · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$485,609
R01 · FY2016 · CA · contact PI
Understanding Wnt signaling through Ror and Ryk family receptor tyrosine kinases$550,611
R01 · FY2015 · GM · contact PI
Understanding EGF receptor activation by growth factors and oncogenic mutations$498,622
R01 · FY2015 · CA · contact PI
Signaling by growth factor receptors with intracellular pseudokinase domains$399,157
R01 · FY2015 · GM · contact PI
Understanding Wnt signaling through Ror and Ryk family receptor tyrosine kinases$550,611
R01 · FY2014 · GM · contact PI
Signaling by growth factor receptors with intracellular pseudokinase domains$399,157
R01 · FY2014 · GM · contact PI
Understanding Wnt signaling through Ror and Ryk family receptor tyrosine kinases$550,611
R01 · FY2013 · GM · contact PI
Signaling by growth factor receptors with intracellular pseudokinase domains$415,847
R01 · FY2013 · GM · contact PI
ErbB receptor homo- and hetero-dimerization$233,168
R01 · FY2013 · CA · contact PI
Signaling by growth factor receptors with intracellular pseudokinase domains$430,294
R01 · FY2012 · GM · contact PI
ErbB receptor homo- and hetero-dimerization$248,051
R01 · FY2012 · CA · contact PI
ErbB receptor homo- and hetero-dimerization$248,051
R01 · FY2011 · CA · contact PI
Mechanisms of invertebrate EGF receptor inhibition$229,476
R01 · FY2011 · CA · contact PI
STRUCTURAL CHARACTERIZATION OF F-BAR DOMAINS$5,487
P41 · FY2011 · RR · contact PI
STRUCTURAL STUDIES OF DROSOPHILA ANAPLASTIC LYMPHOMA KINASE$955
P41 · FY2011 · RR · contact PI
Mechanisms of dynamin family GTPases$267,863
R01 · FY2010 · GM · contact PI
ErbB receptor homo- and hetero-dimerization$255,723
R01 · FY2010 · CA · contact PI
Mechanisms of invertebrate EGF receptor inhibition$236,655
R01 · FY2010 · CA · contact PI
Specificity of domain interactions in cell signaling$216,264
R01 · FY2010 · GM · contact PI
ErbB receptor homo- and hetero-dimerization$427,626
R01 · FY2009 · CA · contact PI
Mechanisms of dynamin family GTPases$270,716
R01 · FY2009 · GM · contact PI
Specificity of domain interactions in cell signaling$267,744
R01 · FY2009 · GM · contact PI
ErbB receptor homo- and hetero-dimerization$255,723
R01 · FY2009 · CA · contact PI
Mechanisms of invertebrate EGF receptor inhibition$236,735
R01 · FY2009 · CA · contact PI
Mechanisms of dynamin family GTPases$270,859
R01 · FY2008 · GM · contact PI
ErbB Receptor Homo-and Hetero-Dimerization$242,017
R01 · FY2008 · CA · contact PI
Mechanisms of invertebrate EGF receptor inhibition$236,813
R01 · FY2008 · CA · contact PI
Mechanisms of dynamin family GTPases$270,790
R01 · FY2007 · GM · contact PI
ErbB Receptor Homo-and Hetero-Dimerization$242,246
R01 · FY2007 · CA · contact PI
Mechanisms of invertebrate EGF receptor inhibition$236,888
R01 · FY2007 · CA · contact PI
Specificity of Domain Interactions in Cell Signaling$282,577
R01 · FY2006 · GM · contact PI
Mechanisms of ErbB2/HER2/Neu Activation$275,500
R01 · FY2006 · CA · contact PI
ErbB Receptor Homo-and Hetero-Dimerization$249,709
R01 · FY2006 · CA · contact PI
Specificity of Domain Interactions in Cell Signaling$289,582
R01 · FY2005 · GM
Mechanisms of ErbB2/HER2/Neu Activation$282,130
R01 · FY2005 · CA
ErbB Receptor Homo-and Hetero-Dimerization$255,945
R01 · FY2005 · CA
Specificity of Domain Interactions in Cell Signaling$289,780
R01 · FY2004 · GM
Mechanisms of ErbB2/HER2/Neu Activation$282,130
R01 · FY2004 · CA
ErbB Receptor Homo-and Hetero-Dimerization$256,165
R01 · FY2004 · CA
Specificity of Domain Interactions in Cell Signaling$289,973
R01 · FY2003 · GM
Mechanisms of ErbB2/HER2/Neu Activation$282,130
R01 · FY2003 · CA
ERBB RECEPTOR HOMO- AND HETERO- DIMERIZATION$215,389
R01 · FY2003 · CA
Mechanisms of ErbB2/HER2/Neu Activation$282,130
R01 · FY2002 · CA
SPECIFICITY OF DOMAIN INTERACTIONS IN CELL SIGNALING$220,473
R01 · FY2002 · GM
ERBB RECEPTOR HOMO- AND HETERO- DIMERIZATION$209,245
R01 · FY2002 · CA
SPECIFICITY OF DOMAIN INTERACTIONS IN CELL SIGNALING$214,949
R01 · FY2001 · GM
ERBB RECEPTOR HOMO- AND HETERO- DIMERIZATION$185,907
R01 · FY2001 · CA
STRUCTURAL STUDIES OF ERBB/HER RECEPTOR DIMERIZATION$118,875
R21 · FY2001 · CA
SPECIFICITY OF DOMAIN INTERACTIONS IN CELL SIGNALING$209,586
R01 · FY2000 · GM
ERBB RECEPTOR HOMO- AND HETERO- DIMERIZATION$157,010
R01 · FY2000 · CA
STRUCTURAL STUDIES OF ERBB/HER RECEPTOR DIMERIZATION$118,875
R21 · FY2000 · CA